RNAimmune Inc., a biopharmaceutical company in Gaithersburg specializing in discovery and development of mRNA-based therapeutics and vaccines, announced Wednesday it has secured $27 million in a Series A round of financing. The company intends to use the funding to accelerate its research and development of mRNA vaccine and drug discovery focused on infectious disease, cancer, and .
/PRNewswire/ The SparX Group of Cayman Island recently announced the closing of a B-round fund-raising of over 30 million USD. Co-founded by Dr. Gui-Dong.
/PRNewswire/ The SparX Group of Cayman Island recently announced the closing of a B-round fund-raising of over 30 million USD. Co-founded by Dr. Gui-Dong.